Chen JS - Search Results

1

Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study.

Chiu TJ, Su YY, Yang SH, Li CP, Bai LY, Chiang NJ, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Chen YY, Chen JS, Chou WC. Chiu TJ, et al. Among authors: chen yy, chen lt, chen js. Ther Adv Med Oncol. 2021 Nov 20;13:17588359211058255. doi: 10.1177/17588359211058255. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34819998 Free PMC article.

2

Transcutaneous arterial embolization to control massive tumor bleeding in head and neck cancer: 63 patients' experiences from a single medical center.

Chou WC, Lu CH, Lin G, Hong YS, Chen PT, Hsu HC, Chen JS, Yeh KY, Wang HM, Liaw CC. Chou WC, et al. Among authors: chen pt, chen js. Support Care Cancer. 2007 Oct;15(10):1185-90. doi: 10.1007/s00520-007-0234-y. Epub 2007 Mar 14. Support Care Cancer. 2007. PMID: 17356807

3

A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.

Chen JS, Rau KM, Chen YY, Huang JS, Yang TS, Lin YC, Liau CT, Lee KD, Su YC, Kao RH. Chen JS, et al. Among authors: chen yy. Cancer Chemother Pharmacol. 2009 Apr;63(5):819-25. doi: 10.1007/s00280-008-0797-4. Epub 2008 Jul 29. Cancer Chemother Pharmacol. 2009. PMID: 18663448 Clinical Trial.

4

Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer.

Ch'ang HJ, Huang CL, Wang HP, Shiah HS, Chang MC, Jan CM, Chen JS, Tien YW, Hwang TL, Lin JT, Cheng AL, Whang-Peng J, Chen LT. Ch'ang HJ, et al. Among authors: chen lt, chen js. Cancer Chemother Pharmacol. 2009 Nov;64(6):1173-9. doi: 10.1007/s00280-009-0980-2. Epub 2009 Mar 25. Cancer Chemother Pharmacol. 2009. PMID: 19319535 Clinical Trial.

5

A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma.

Chen JS, Chao Y, Yang TS, Chou WC, Chen LT, Lee KD, Lin YC. Chen JS, et al. Among authors: chen lt. Cancer Chemother Pharmacol. 2009 Dec;65(1):151-7. doi: 10.1007/s00280-009-1018-5. Epub 2009 May 20. Cancer Chemother Pharmacol. 2009. PMID: 19455334 Clinical Trial.

6

A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.

Chen JS, Chao Y, Hsieh RK, Cheng AL, Chen PM, Chiou TJ, Chao TY, Yeh KH, Chen LT, Whang-Peng J. Chen JS, et al. Among authors: chen lt, chen pm. Cancer Chemother Pharmacol. 2011 Jun;67(6):1281-9. doi: 10.1007/s00280-010-1416-8. Epub 2010 Aug 17. Cancer Chemother Pharmacol. 2011. PMID: 20714726 Clinical Trial.

7

Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study.

Ch'ang HJ, Lin YL, Wang HP, Chiu YF, Chang MC, Hsu CH, Tien YW, Chen JS, Hsieh RK, Lin PW, Shan YS, Cheng AL, Chang JY, Whang-Peng J, Hwang TL, Chen LT. Ch'ang HJ, et al. Among authors: chen lt, chen js. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e749-57. doi: 10.1016/j.ijrobp.2010.10.034. Epub 2011 Mar 21. Int J Radiat Oncol Biol Phys. 2011. PMID: 21420250 Clinical Trial.

8

A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.

Chen JS, Chen YY, Huang JS, Yeh KY, Chen PT, Shen WC, Hsu HC, Lin YC, Wang HM. Chen JS, et al. Among authors: chen yy, chen pt. Gastric Cancer. 2012 Jan;15(1):49-55. doi: 10.1007/s10120-011-0060-2. Epub 2011 Jun 8. Gastric Cancer. 2012. PMID: 21655995 Clinical Trial.

9

Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from Taiwan.

Yeh CN, Chen YY, Tseng JH, Chen JS, Chen TW, Tsai CY, Cheng CT, Jan YY, Chen MF. Yeh CN, et al. Among authors: chen yy, chen tw, chen js, chen mf. Transl Oncol. 2011 Dec;4(6):328-35. doi: 10.1593/tlo.11253. Epub 2011 Dec 1. Transl Oncol. 2011. PMID: 22190996 Free PMC article.

10

Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients.

Chou WC, Hung YS, Hsu JT, Chen JS, Lu CH, Hwang TL, Rau KM, Yeh KY, Chen TC, Sun CF. Chou WC, et al. Among authors: chen tc, chen js. Neuroendocrinology. 2012;95(4):344-50. doi: 10.1159/000333853. Epub 2012 Feb 14. Neuroendocrinology. 2012. PMID: 22343505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,197 results

Search Page

Filters